Lilly Announces First-Quarter 2026 Dividend
But here’s the essential fact upfront: Eli Lilly and Company will pay a dividend of $1.73 per share on its outstanding common stock for the first quarter of 2026. The payout is scheduled for March 10, 2026, to investors who own shares as of the close of business on February 13, 2026.
About Lilly
Lilly is a global medical company focused on turning scientific discoveries into better health outcomes. With nearly 150 years of pioneering work, Lilly’s medicines help tens of millions of people around the world. The company leverages biotechnology, chemistry, and genetic medicine to tackle some of the world’s toughest health challenges, including redefining diabetes care, addressing obesity and its long-term effects, advancing Alzheimer’s disease research, treating immune system disorders, and transforming hard-to-treat cancers into manageable conditions.
Purpose and accessibility remain central: Lilly aims to improve lives by advancing innovative clinical trials that reflect the world’s diversity and by making therapies more accessible and affordable. For more details, explore Lilly’s official site and news portal, or connect via its social channels on Facebook, Instagram, and LinkedIn.
Forward-Looking Statements
This press release includes forward-looking statements about expected dividend payments and reflects Lilly’s present beliefs and expectations. Nevertheless, biological research, development, and capital-allocation decisions carry significant risks and uncertainties. Actual results may differ materially due to factors in pharmaceutical development and business activities. For a thorough discussion of these risks, refer to Lilly’s Form 10-K and Form 10-Q filings with the U.S. Securities and Exchange Commission. Lilly does not undertake any obligation to update forward-looking statements beyond what laws require.
Source: Eli Lilly and Company
